Jury Verdict in Favor of Firm Client Avid Radiopharmaceuticals

FOR IMMEDIATE RELEASE

April 20, 2012

Contact:    Charles E. Lipsey, 571.203.2755

                    Partner

Jury Verdict in Favor of Firm Client Avid Radiopharmaceuticals

WASHINGTON, DC - On April 20, 2012, a two-week trial was held on the issue of whether plaintiff Alzheimer’s Institute of America, Inc. had standing to bring a patent infringement action against Avid Radiopharmaceuticals, Inc., a subsidiary of Eli Lilly and Company. The jury in the U.S. District Court for the Eastern District of Pennsylvania found for Avid and Penn. Specifically, the jury found that the academic institution where the alleged sole inventor was employed had not waived its rights in the invention, that the inventor listed on the issued patents was not the sole inventor, and that John Hardy was a co-inventor.

About Finnegan

With more than 375 intellectual property lawyers, Finnegan is one of the largest IP law firms in the world. From offices in Washington, DC; Atlanta, Georgia; Cambridge, Massachusetts; Palo Alto, California; Reston, Virginia; Brussels, Belgium; Shanghai, China; Taipei, Taiwan; and Tokyo, Japan, the firm practices all aspects of patent, trademark, copyright, and trade secret law, including counseling, prosecution, licensing, and litigation. Finnegan also represents clients on IP issues related to international trade, portfolio management, the Internet, e-commerce, government contracts, antitrust, and unfair competition. For additional information on the firm, please visit www.finnegan.com. ###